Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results
Go back to Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.43 +0.21 (3.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.22 | 52 Week High | $44.38 | |||
| Open | $6.23 | 52 Week Low | $24.47 | |||
| Day High | $6.49 | P/E | 321.50 | |||
| Day Low | $6.23 | EPS | $0.02 | |||
| Volume | 587,734 | |||||
